Literature DB >> 9014666

One hundred and fifty hepatic resections: evolution of technique towards bloodless surgery.

M Rees1, G Plant, J Wells, S Bygrave.   

Abstract

A technique of hepatic resection is described and the results of 150 resections are reviewed. Hepatic transection was performed, under intermittent portal inflow occlusion, using ultrasonic aspiration to skeletonize portal branches and venous tributaries. Control of venous haemorrhage during resection was optimized by argon beam coagulation and lowering central venous pressure to between 0 and 4 cmH2O by extradural blockade and systemic nitroglycerine infusion. One patient with jaundice died in hospital, giving a mortality rate of 0.7 per cent. There were no deaths in patients without jaundice and cirrhosis. Fifteen patients (10.0 per cent) had significant complications, nine medical and six surgical, including three bile leaks (2.0 per cent). Mean blood loss was 814 ml for the whole study but only 434 ml in the last 4 years. During this latter period mean blood transfusion in hospital was 0.5 units and mean postoperative haemoglobin value fell by 0.7 g per 100 ml. Hepatic resection can be performed with the same degree of confidence and similar low morbidity as any other major surgical procedure.

Entities:  

Mesh:

Year:  1996        PMID: 9014666     DOI: 10.1002/bjs.1800831110

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  50 in total

1.  Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Drain-free parotidectomy: a pilot study using ARTISS fibrin sealant.

Authors:  H A Cunniffe; B L K Wong; A W Hilger; O T Burgan
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-28       Impact factor: 2.503

3.  Hepatic surgery using the Ligasure vessel sealing system.

Authors:  Fabrizio Romano; Claudio Franciosi; Roberto Caprotti; Fabio Uggeri; Franco Uggeri
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

4.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 5.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

6.  Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.

Authors:  Cheng-Chung Wu; Wai-Meng Ho; Shao-Bin Cheng; Dah-Cherng Yeh; Mei-Chin Wen; Tse-Jia Liu; Fang-Ku P'eng
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

7.  Intraoperative blood salvage during liver resection: a randomized controlled trial.

Authors:  Takuya Hashimoto; Norihiro Kokudo; Ryo Orii; Yasuji Seyama; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Kiyoshi Hasegawa; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  An electrode array that minimizes blood loss for radiofrequency-assisted hepatic resection.

Authors:  D J Schutt; A P O'Rourke; J A Will; J G Webster; D M Mahvi; D Haemmerich
Journal:  Med Eng Phys       Date:  2007-06-27       Impact factor: 2.242

9.  Parenchymal transection with ultrasonic scalpel in liver resection.

Authors:  O Abbasoglu; I Sayek
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

10.  Comparison of two different transection techniques in liver surgery-an experimental study in a porcine model.

Authors:  T Gehrig; G Manzini; H Fonouni; M Golriz; R Hafezi; N Rahbari; K Brand; U Hinz; B P Müller-Stich; C N Gutt; A Mehrabi
Journal:  Langenbecks Arch Surg       Date:  2013-06-20       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.